Show Summary Details
Page of

Ventricular assist devices 

Ventricular assist devices
Ventricular assist devices

A Rosenberg

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 August 2021

Principles 298

Indications 299

Types of VADs 300

Anaesthetic management during VAD placement 302

Complications 304

Further reading 305

Though ventricular assist devices (VADs) have been available for over 20 years, they have become more prevalent due to increased numbers of patients with end-stage heart failure, limited access to transplantation, and improved device technologies. These may allow patients to ambulate, participate in cardiac rehabilitation, await transplant at home (bridge to transplant), or may constitute a permanent treatment (destination therapy). The REMATCH trial of 129 randomized patients demonstrated a 48% reduced one-year mortality with permanent LVAD treatment versus best medical management....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.